Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-02-09
1999-03-30
Burn, Brain M
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514427, 514428, 514429, 546337, 548561, 564189, 564190, 564212, A61K 3144
Patent
active
058890319
ABSTRACT:
Certain N-acyl 2-aryl cyclopropylmethylamine derivatives are useful as melatonergic agents.
REFERENCES:
patent: 3562276 (1971-02-01), Teotino et al.
patent: 3646146 (1972-02-01), Teotino et al.
patent: 5276051 (1994-01-01), Lesieur et al.
patent: 5521212 (1996-05-01), Ikeda et al.
patent: 5776969 (1998-07-01), James et al.
patent: 5780512 (1998-07-01), Lesieur et al.
Arendt, et al., "Alleviation of Jet Lag by Melatonin: Preliminary Results of Controlled Double Blind Trail," Br. Med. J., 292: 1170 (1986).
Cassone, et al., "Dose-Dependent Entrainment of Rad Circadian Rhythms by Daily Injection of Melatonin," J. Biol. Rhythms, 1: 219-229 (1986).
Bonnaud, et al., J. Med. Chem., 30: 318-325.
Johnson Graham
Keavy Daniel J.
Mattson Ronald J.
Parker Michael F.
Algieri Aldo A.
Bristol-Myers Squibb Compnay
Burn Brain M
LandOfFree
N-acyl-2-aryl cyclopropylmethylamine derivatives as melatonergic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-acyl-2-aryl cyclopropylmethylamine derivatives as melatonergic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acyl-2-aryl cyclopropylmethylamine derivatives as melatonergic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1215492